Patients with COVID-19 have experienced increased sleep disturbances, and individuals who have been more affected by the pandemic had increased nightmares, prior studies have shown. This is the first study of the oneiric activity of people with COVID-19 and the first comparing their oneiric activity with those of individuals who have not had COVID-19.
For children with insomnia symptoms, 43.3% have a persistent trajectory.
In 2 phase 3 randomized controlled trials, researchers assessed the safety and efficacy of daridorexant on nighttime and daytime symptoms of insomnia.
Researchers sought to determine whether a real-time clinical decision support tool can help physicians identify clinically stable patients and safely discontinue overnight vital sign checks.
Quviviq is a dual orexin receptor antagonist.
Researchers sought to compare the benefits of cognitive behavioral therapy for insomnia for sleep, mental health symptoms, and quality of life in women veterans with and without probable PTSD with insomnia.
Researchers provided practical tips and management approach strategies for the treatment of severe irritable bowel syndrome.
A team of researchers plans to test the feasibility and acceptability of cognitive behavioral therapy for veterans with insomnia and alcohol use disorder.
The researchers investigated an informally reported effect in which time seems to pass more quickly while playing games in virtual reality.
Researchers strove to provide robust estimates of incidence rates and relative risks of neurologic and psychiatric diagnoses in patients in the 6 months following a COVID-19 diagnosis.
